Current nursing practice for patients on oral chemotherapy: a multicenter survey in Japan

BMC Research Notes

Kimio Yoshimura²  Kaori Yagasaki¹  Hiroko Komatsu¹ 

[1] Faculty of Nursing and Medical Care, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan;Department of Health Policy and Management, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan

关键词: Medication management;    Interdisciplinary care;    Compliance;    Medication adherence;    Oral chemotherapy;   

Others  :  1133260
DOI  :  10.1186/1756-0500-7-259

 received in 2014-01-29, accepted in 2014-04-14,  发布年份 2014

【 摘 要 】

Background

With a paradigm shift toward a chronic care model in cancer, the issue of adherence is becoming increasingly important in oncology.

Methods

We mailed two self-reported surveys on current nursing practices for patients on oral chemotherapy to all 309 designated cancer centers and 141 large general hospitals in Japan. The first survey was based on a nurse-based questionnaire containing 40 items concerning nurse’s characteristics, nurse staffing at workplace, general nursing care for new patients on oral chemotherapy and those with refilled prescriptions, follow-up, and system-based approach. The second survey was based on a patient-based questionnaire containing 10 items about patient characteristics and adherence-related nursing practice for 249 patients taking oral chemotherapy of 903 systematically sampled. We used multivariate logistic regression to identify factors that were associated with adherence-related nursing practices.

Results

A total of 62 nurses (mean age: 41.5 years) from 62 hospitals who consented participated in the both nurse-based survey and patient-based survey about 249 patients. The results of nurse-based survey indicated that practices varied, but nurses were less likely to ask adherence-related questions of patients with refilled prescriptions than of new patients. The results of patient-based survey found that questions on side effects, discussions about barriers to achieving balance between treatment and daily life activities, and medication management were all significantly related to the question about unused medicines. Logistic regression revealed that adherence-related nursing practices were associated with the nurse’s background, type of treatment, and healthcare system-related factors. Patient orientation on oral chemotherapy, interdisciplinary learning, and having a system-based approach for detecting prescription errors were identified as healthcare system-related factors.

Conclusions

A more systematic approach must be developed to ensure patients receive safe and effective oral chemotherapy, while nurses should play significant roles in patient education and monitoring.

【 授权许可】

   
2014 Komatsu et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Given BA, Spoelstra SL, Grant M: The challenges of oral agents as antineoplastic treatments. Semin Oncol Nurs 2011, 27:93-103.
• [2]Moody M, Jackowski J: Are patients on oral chemotherapy in your practice setting safe? Clin J Oncol Nurs 2010, 14:339-346.
• [3]Verbrugghe M, Verhaeghe S, Lauwaert K, Beeckman D, Van Hecke A: Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: a systematic review. Cancer Treat Rev 2013, 39:610-621.
• [4]Wood L: A review on adherence management in patients on oral cancer therapies. Eur J Oncol Nurs 2012, 16:432-438.
• [5]Winkeljohn DL: Oral chemotherapy medications: the need for a nurse’s touch. Clin J Oncol Nurs 2007, 11:793-796.
• [6]Fallowfield L, Atkins L, Catt S, Cox A, Coxon C, Langridge C, Morris R, Price M: Patients’ preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer. Ann Oncol 2006, 17:205-210.
• [7]Neuss MN, Polovich M, McNiff K, Esper P, Gilmore TR, LeFebvre KB, Schulmeister L, Jacobson JO: 2013 updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards including standards for the safe administration and management of oral chemotherapy. Oncol Nurs Forum 2013, 40:225-233.
• [8]Foulon V, Schoffski P, Wolter P: Patient adherence to oral anticancer drugs: an emerging issue in modern oncology. Acta Clin Belg 2011, 66:85-96.
• [9]Partridge AH, Avorn J, Wang PS, Winer EP: Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst 2002, 94:652-661.
• [10]Ruddy K, Mayer E, Partridge A: Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin 2009, 59:56-66.
• [11]Kruse GB, Amonkar MM, Smith G, Skonieczny DC, Stavrakas S: Analysis of costs associated with administration of intravenous single-drug therapies in metastatic breast cancer in a U.S. population. J Manag Care Pharm 2008, 14:844-857.
• [12]Osterberg L, Blaschke T: Adherence to medication. N Engl J Med 2005, 353:487-497.
• [13]Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock SJ, Wines RC, Coker-Schwimmer EJ, Rosen DL, Sista P, Lohr KN: Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med 2012, 157:785-795.
• [14]Hartigan K: Patient education: the cornerstone of successful oral chemotherapy treatment. Clin J Oncol Nurs 2003, 7:21-24.
• [15]Halfdanarson TR, Jatoi A: Oral cancer chemotherapy: the critical interplay between patient education and patient safety. Curr Oncol Rep 2010, 12:247-252.
• [16]Kav S, Johnson J, Rittenberg C, Fernadez-Ortega P, Suominen T, Olsen PR, Patiraki E, Porock D, Dahler A, Toliusiene J, Tadic D, Pittayapan P, Roy V, Wang Q, Colak M, Saca-Hazboun H, Makumi D, Kadmon I, Ami SB, Anderson E, Clark-Snow R: Role of the nurse in patient education and follow-up of people receiving oral chemotherapy treatment: an international survey. Support Care Cancer 2008, 16:1075-1083.
• [17]Roop JC, Wu HS: Current practice patterns for oral chemotherapy: results of a national survey. Oncol Nurs Forum 2014, 41:185-194. doi:10.1188/14.ONF.41-02AP
• [18]Yagasaki K, Komatsu H: The need for a nursing presence in oral chemotherapy. Clin J Oncol Nurs 2013, 17:512-516.
• [19]Thompson K, Kulkarni J, Sergejew AA: Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res 2000, 42:241-247.
• [20]Kav S, Schulmeister L, Nirenberg A, Barber L, Johnson J, Rittenberg C: Development of the MASCC teaching tool for patients receiving oral agents for cancer. Support Care Cancer 2010, 18:583-590.
• [21]Sommers RM, Miller K, Berry DL: Feasibility pilot on medication adherence and knowledge in ambulatory patients with gastrointestinal cancer. Oncol Nurs Forum 2012, 39:E373-E379.
• [22]Winkeljohn D: Adherence to oral cancer therapies: nursing interventions. Clin J Oncol Nurs 2010, 14:461-466.
• [23]Kalogianni A: Can Nursing Interventions increase adherence medication regimen? Health Sci J 2012, 6:1-3. [http://www.hsj.gr/volume6/issue1/610.pdf webcite]
• [24]Marrs J, Zubal BA: Oncology nursing in a new era: optimizing treatment with bevacizumab. Clin J Oncol Nurs 2009, 13:564-572.
• [25]Jacobson JO, Polovich M, Gilmore TR, Schulmeister L, Esper P, Lefebvre KB, Neuss MN: Revisions to the 2009 American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards: expanding the scope to include inpatient settings. Oncol Nurs Forum 2012, 39:31-38.
• [26]Ueno NT, Ito TD, Grigsby RK, Black MV, Apted J: ABC conceptual model of effective multidisciplinary cancer care. Nat Rev Clin Oncol 2010, 7:544-547.
• [27]Soubhi H, Colet NR, Gilbert JH, Lebel P, Thivierge RL, Hudon C, Fortin M: Interprofessional learning in the trenches: fostering collective capability. J Interprof Care 2009, 23:52-57.
• [28]Font R, Espinas JA, Gil-Gil M, Barnadas A, Ojeda B, Tusquets I, Segui MA, Margeli M, Arcusa A, Prat A, Garcia M, Borras JM: Prescription refill, patient self-report and physician report in assessing adherence to oral endocrine therapy in early breast cancer patients: a retrospective cohort study in Catalonia, Spain. Br J Cancer 2012, 107:1249-1256.